22 min listen
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
ratings:
Length:
47 minutes
Released:
Sep 11, 2020
Format:
Podcast episode
Description
For this special edition of Oncology Today, I met with Dr Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle to discuss recently published and emerging research on the use of immunotherapy in the management of urothelial bladder carcinoma.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayUBCImmuno20).
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayUBCImmuno20).
Released:
Sep 11, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love